Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

1.

Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment.

Flynn JK, Dore GJ, Hellard M, Yeung B, Rawlinson WD, White PA, Kaldor JM, Lloyd AR, Ffrench RA; ATAHC Study Group.

J Gastroenterol Hepatol. 2013 Nov;28(11):1770-81. doi: 10.1111/jgh.12265.

PMID:
23663030
[PubMed - indexed for MEDLINE]
2.

Impaired hepatitis C virus (HCV)-specific interferon-γ responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell counts.

Flynn JK, Dore GJ, Matthews G, Hellard M, Yeung B, Rawlinson WD, White PA, Kaldor JM, Lloyd AR, Ffrench RA; ATAHC Study Group.

J Infect Dis. 2012 Nov 15;206(10):1568-76. doi: 10.1093/infdis/jis544. Epub 2012 Sep 4.

PMID:
22949308
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection.

Alavi M, Grebely J, Matthews GV, Petoumenos K, Yeung B, Day C, Lloyd AR, Van Beek I, Kaldor JM, Hellard M, Dore GJ, Haber PS; ATAHC Study Group.

J Gastroenterol Hepatol. 2012 May;27(5):957-65. doi: 10.1111/j.1440-1746.2011.07035.x.

PMID:
22142332
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C.

Matthews GV, Pham ST, Hellard M, Grebely J, Zhang L, Oon A, Marks P, van Beek I, Rawlinson W, Kaldor JM, Lloyd A, Dore GJ, White PA; ATAHC Study Group.

Clin Infect Dis. 2011 Mar 15;52(6):803-11. doi: 10.1093/cid/ciq200. Epub 2011 Jan 31.

PMID:
21282185
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.

Grebely J, Petoumenos K, Hellard M, Matthews GV, Suppiah V, Applegate T, Yeung B, Marks P, Rawlinson W, Lloyd AR, Booth D, Kaldor JM, George J, Dore GJ; ATAHC Study Group.

Hepatology. 2010 Oct;52(4):1216-24. doi: 10.1002/hep.23850.

PMID:
20803561
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.

Grebely J, Petoumenos K, Matthews GV, Haber P, Marks P, Lloyd AR, Kaldor JM, Dore GJ, Hellard M; ATAHC Study Group.

Drug Alcohol Depend. 2010 Mar 1;107(2-3):244-9. doi: 10.1016/j.drugalcdep.2009.09.015.

PMID:
19926405
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Effective treatment of injecting drug users with recently acquired hepatitis C virus infection.

Dore GJ, Hellard M, Matthews GV, Grebely J, Haber PS, Petoumenos K, Yeung B, Marks P, van Beek I, McCaughan G, White P, French R, Rawlinson W, Lloyd AR, Kaldor JM; Australian Trial In Acute Hepatitis C Study Group.

Gastroenterology. 2010 Jan;138(1):123-35.e1-2. doi: 10.1053/j.gastro.2009.09.019. Epub 2009 Sep 24.

PMID:
19782085
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza.

Goy K, Von Bibra S, Lewis J, Laurie K, Barr I, Anderson D, Hellard M, Ffrench R.

Influenza Other Respir Viruses. 2008 Jul;2(4):115-25. doi: 10.1111/j.1750-2659.2008.00046.x.

PMID:
19453462
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk